SCHEMBL6791098

SCHEMBL6791098

O=C(Nc1ccc(S(=O)(=O)CC2(C(=O)NO)CCNCC2)cc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 6/20 0.61
MMP2 P08253 7/20 0.54
MMP13 P45452 6/20 0.54
HDAC1 Q13547 1/20 0.49
PRMT1 Q99873 2/20 0.49
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
HPGD P15428 1/20 0.47
MMP1 P03956 4/20 0.46
MMP9 P14780 4/20 0.46
MMP14 P50281 4/20 0.46
MMP3 P08254 2/20 0.46
LMNA P02545 1/20 0.46
ABCB11 O95342 1/20 0.43
MMP7 P09237 1/20 0.43
MMP10 P09238 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6790716 0.81 MMP1 (0.66) ADAM17MMP2MMP13MMP1MMP9
SCHEMBL6791077 0.79 ADAM17 (0.68) ADAM17MMP2MMP13MMP1MMP9
SCHEMBL7310372 0.73 MMP13 (0.76) ADAM17MMP2MMP13MMP1MMP9
SCHEMBL5919480 0.72 MMP1 (0.64) MMP2MMP13PRMT1MEN1KMT2A
SCHEMBL6796907 0.71 HDAC1 (0.54) HDAC1MEN1KMT2ALMNA
SCHEMBL7681442 0.70 MMP1 (0.55) ADAM17MMP2MMP13MMP1MMP9
SCHEMBL6753832 0.70 ADAM17 (1.00) ADAM17MMP2MMP13MMP1MMP9
SCHEMBL7362510 0.70 ADAM17 (0.58) ADAM17MMP2MMP13MMP1MMP9
SCHEMBL22501838 0.69 KDM4E (0.68) PRMT1MEN1KMT2ALMNA
SCHEMBL6764979 0.69 PRMT1 (0.57) MMP2PRMT1MEN1KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097487-A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds G.D. SEARLE & CO. 2004-05-20 US disclosed
US-6638952-B1 Matrix metalloprotease inhibitors PHARMACIA CORPORATION 2003-10-28 US disclosed
EP-0983257-A4 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS MONSANTO CO (US) 2001-05-02 EP disclosed
EP-0983257-A1 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS Monsanto Company (US) 2000-03-08 EP disclosed
WO-1998039315-A1 AROMATIC SULFONYL ALPHA-CYCLOAMINO HYDROXAMIC ACID COMPOUNDS MONSANTO COMPANY (US) 1998-09-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097487-A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds MMP1, MMP2, MMP10 ADAM17 24/4885MMP2 2/4885MMP13 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.